PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Electronic address: jferg1@stanford.edu.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.\', \'Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA; Clinical Microbiology Laboratory, Stanford Health Care, Palo Alto, California, USA.\', \'Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00542-710.1016/j.ijid.2021.06.054
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34216738
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all